Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Case ReportClinical Studies

Primary Amyloidosis of the Eyelid: A Case Report

ALESSIO CAGGIATI, ANTONNIO CAMPANELLA, STEFANIA TENNA, ANNALISA COGLIANDRO, CLEMENTE POTENZA and PAOLO PERSICHETTI
In Vivo July 2010, 24 (4) 575-578;
ALESSIO CAGGIATI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANTONNIO CAMPANELLA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEFANIA TENNA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.tenna@unicampus.it
ANNALISA COGLIANDRO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CLEMENTE POTENZA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PAOLO PERSICHETTI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The Authors describe a case of primary localized amyloidosis of the eyelids, focusing on diagnosis and possible treatment. The involment of several structures of the eyelid such as muscles, conjunctiva and puncta lacrimalia, as well as peculiar features of these proteinaceous deposits, suggest different combined procedures and precise timing in choosing the appropriated therapy.

  • Palpebral amyloidosis
  • eyelid ptosis
  • conjunctival plaque

Amyloidosis is mainly a systemic disease with possible localization involving different organs. These deposits have a specific tropism for connective tissue and perivascular spaces and are characterized by an abnormal extracellular deposit of an amorphous proteic material with specific ultra structural features. Clinical classification includes five groups: primary systemic, primary localized, secondary to a chronic illnesses, secondary to multiple myeloma, and familiar type. The involvement of the oculo-palpebral region may occur only in the first two forms and may affect different structures such as the cornea, the vitreous body, the lacrimal glands, extraocular striated and smooth (Muller) muscles, the conjunctiva and eyelids (1-4). The clinical picture in conjunctival and eyelid amyloidosis localization may consist of eyelid oedema, papules and yellowish subconjunctival plaques (crumbly, easily bleeding and able to affect the entire surface of the palpebral conjunctiva), signs of conjunctival irritation, lumps or swellings and an eyelid ptosis. The ptosis may be due to a mass that dislocates the eyelid free margin or have a functional pathogenesis if the Muller muscle is affected by the disease (5-8).

The diagnosis of eyelid primary amyloidosis is based on symptoms, patient's anamnesis, clinical examination and finally a biopsy specimen (9, 10). Radiological examinations, tomography or ultrasound are useful for the correct therapeutical approach and to exclude a possible systemic involvement of the disease. The medical treatment of symptomatic primary eyelid amyloidosis is based on the use of ascorbic acid to reduce the bleeding tendency of these lesions and anti-inflammatory drugs, locally or general. The surgical approach is based on the resection of the affected structures, with direct closure of the areas of loss in the initial localized forms, or with more complex and different reconstructive procedures in cases of greater extent of lesions (11). Other therapeutic options are electro-cauterization, cryotherapy, and selective debridement (12).

Case Report

A 30-year-old man affected by a primary amyloidosis bilaterally localized in the eyelids presented with a mild degree of ptosis on the left and a moderate degree on the right side associated with severe oedema of the lower lids (Figure 1). At the clinical examination, moderate swelling, 1 cm large, was apparent in the medial part of right upper eyelid, mobile to the overlying skin, which seemed to cause the downward displacement of the free eyelid margin and the disappearance of the superior orbital sulcus. On the inside of the eyelids, upper and lower, the patient had extensive bilateral yellowish conjunctival vegetations, easily bleeding, which also affected the conjunctival fornix, the internal canthus and puncta lacrimalia (Figures 2 and 3). The patient had routine preoperative laboratory tests, ophthalmological evaluation, palpebral ultrasound and orbital tomographic examinations. The specific tests showed hypoechogenicity of the lesions and the involvement of the surrounding structures (Figure 4). The patient underwent two sessions of a combined treatment with electrocauterization and CO2 laser vaporization to reduce the conjunctival vegetations and a surgical resection of eyelid swelling, which, intraoperatively, had the appearance of a cyst with a colourless gelatinous content. In the postoperative period the patient had antibiotic therapy by oral (4 days) and topical (14g) administration. No complications were recorded and the patient was discharged on the third day. Follow-up at six months and after 1 year showed a permanent correction of the eyelid ptosis and a significant reduction of ocular symptoms despite limited residual lesions on the conjunctiva (Figures 5, 6, 7 and 8).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Preoperative frontal view.

Discussion

Primary eyelid amyloidosis is a rare clinical entity that often leads to misdiagnosis. Differential diagnosis includes basal cell or squamous cell carcinoma, lachrymal gland carcinoma or lymphoma (13, 14). Ultrasonography and tomography are usually able to suggest the correct diagnosis but they are also mandatory to establish the relationships of the masses with the surrounding structures before surgery. Moreover, general clinical examination and ophthalmologic tests are also indicated to complete the preoperative evaluation which should lead to a correct therapeutic strategy, avoiding partial or multiple treatments. In fact, a surgical approach alone may often be associated with a high risk of incomplete excision and local recurrence, in the early or late postoperative period. Radical surgical excision, even in highly specialized oculoplastic centres, may cause severe impairment of both structure and function of the eyelid (15). For these reasons, other methods such as electro cauterization, cryotherapy, selective curettage and radiotherapy have already been described in addition to surgery as useful tools to remove subconjunctival amyloid vegetations (16).

Our experience confirmed that combined procedures are the gold standard treatment of these lesions. Localized masses should always be excised surgically since amyloid swelling does not present as encapsulated cyst and the deposits are often scattered inside the tissue, simply limited by an area of increased thickness. Particular care must be paid when the Muller muscle or the elevator muscle of the upper eyelid are involved in order to avoid a secondary ptosis, as well as when the lesions surround the puncta lacrimalia. The treatment of this area, in fact, must be carried out with extreme caution to avoid iatrogenic injury to lachrymal ducts which can cause permanent epiphora.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Preoperative focus on conjunctival deposits on the right eye.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Preoperative focus on the left eye.

Subconjunctival amyloid vegetations are instead to be treated with other methods. In our opinion, the use of CO2 laser should be preferred due to a lower risk of pathological scarring; radiotherapy and other techniques may result in more severe side-effects and are not to be considered a first choice, especially for a benign disease. Specific attention must be paid to prevent the onset of postoperative complications such as conjunctiva sinechiae that may occur in the case of mirror lesions. Therefore, amyloid deposits on conjunctival fornixes, whether palpebral or bulbar, should always be treated in multiple sessions in order to limit unfavourable healing (17).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Preoperative CT scan.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Postoperative frontal view.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Postoperative view of right conjunctiva and punctum lacrimalis.

Finally, the timing of surgical procedures should be made on the basis of the symptoms. The indication for a surgical treatment comes mainly from the patient's clinical presentation. In any case, regarding the frequency of recurrences of this disease, less invasive treatments should be preferred.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Postoperative view of left conjunctiva.

Figure 8.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 8.

Postoperative CT scan.

Conclusion

The therapeutic issues involved in treating eyelid amyloidosis are still numerous and insoluble. The awareness that there is not any one radical treatment is certainly frustrating for the surgeon, but the benign nature of the disease demands a multidisciplinary approach in qualified centres.

  • Received October 19, 2009.
  • Revision received May 19, 2010.
  • Accepted May 24, 2010.
  • Copyright © 2010 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

References

  1. ↵
    1. Brownstein MH,
    2. Elliott R,
    3. Helwig EB
    : Ophthalmologic aspects of amyloidosis. Am J Ophthalmol 69(3): 423-430, 1970.
    OpenUrlPubMed
    1. Rosenblatt M,
    2. Spitz GF,
    3. Friedman AH,
    4. Kazam ES
    : Localized conjunctival amyloidosis: case reports and review of literature Ophthalmologica 192(4): 238-245, 1986.
    OpenUrlPubMed
    1. Kosch G,
    2. Meyer-Rüsenberg HW
    : Primary localized amyloidosis of the eyelid and conjunctiva. Klin Monatsbl Augenheilkd 202(1): 56-59, 1993.
    OpenUrlPubMed
  2. ↵
    1. Richlin JJ,
    2. Kuwabara T
    : Amyloid disease of the eyelid and conjunctiva. Arch Ophthalmol 67: 138-142, 1962.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Fett DR,
    2. Putterman AM
    : Primary localized amyloidosis presenting as an eyelid margin tumor. Arch Ophthalmol 104(4): 584-585, 1986.
    OpenUrlCrossRefPubMed
    1. Macoul KL,
    2. Winter FC
    : External ophthalmoplegia secondary to systemic amyloidosis. Arch Ophthalmol 79(2): 182-4, 1968.
    OpenUrlCrossRefPubMed
    1. Cheong-Leen R
    : Primary localised conjunctival amyloidosis presenting as subconjunctival haemorrhage. Eye 15(Pt 5): 679-680, 2001.
    OpenUrlPubMed
  4. ↵
    1. Mahajan D,
    2. Yadava U,
    3. Khurana N,
    4. Goyal JL
    : Primary localised nodular amyloidosis of the eyelid and conjunctiva: a case report. Pathology 38(2): 189-190, 2006.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Ramsey MS,
    2. Fine BS,
    3. Cohen SW
    : Localized corneal amyloidosis: case report with electron microscopic observations. Am J Ophthalmol 73(4): 560-565, 1972.
    OpenUrlPubMed
  6. ↵
    1. Bozkurt B,
    2. Kiratli H,
    3. Soylemezoglu F,
    4. Irkec M
    : In vivo confocal microscopy in a patient with conjunctival amyloidosis. Clin Experiment Ophthalmol 36(2): 173-175, 2008.
    OpenUrlPubMed
  7. ↵
    1. Patrinely JR,
    2. Koch DD
    : Surgical management of advanced ocular adnexal amyloidosis. Arch Ophthalmol 110(6): 882-885, 1992.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Pecora JL,
    2. Sambursky JS,
    3. Vargha Z
    : Radiation therapy in amyloidosis of the eyelid and conjunctiva: a case report. Ann Ophthalmol 14(2): 194-196, 1982.
    OpenUrlPubMed
  9. ↵
    1. Spitellie PH,
    2. Jordan DR,
    3. Gooi P,
    4. Brownstein S,
    5. Burns BF
    : Primary localized conjunctival amyloidosis simulating a lymphoproliferative disorder. Ophthal Plast Reconstr Surg 24(5): 417-419, 2008.
    OpenUrlPubMed
  10. ↵
    1. Lezrek M,
    2. Dahreddine M,
    3. Bencherif Z,
    4. Karim A,
    5. Maher M,
    6. Tachfouti S,
    7. Karmane A,
    8. Mohcine Z
    : Bilateral primary pseudotumoral palpebral amyloidosis. A case report. J Fr Ophtalmol 30(6): e17, 2007.
    OpenUrlPubMed
  11. ↵
    1. Iijima S
    : Primary systemic amyloidosis: a unique case complaining of diffuse eyelid swelling and conjunctival involvement. J Dermatol 19(2): 113-118, 1992.
    OpenUrlPubMed
  12. ↵
    1. Demirci H,
    2. Shields CL,
    3. Eagle RC Jr,
    4. Shields JA
    : Conjunctival amyloidosis: report of six cases and review of the literature. Surv Ophthalmol 51(4): 419-433, 2006.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Rodrigues G,
    2. Sanghvi V,
    3. Lala M
    : A rare cause of unilateral upper and lower eyelid swelling: isolated conjunctival amyloidosis. Korean J Ophthalmol 15(1): 38-40, 2001
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

In Vivo: 24 (4)
In Vivo
Vol. 24, Issue 4
July-August 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Primary Amyloidosis of the Eyelid: A Case Report
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Primary Amyloidosis of the Eyelid: A Case Report
ALESSIO CAGGIATI, ANTONNIO CAMPANELLA, STEFANIA TENNA, ANNALISA COGLIANDRO, CLEMENTE POTENZA, PAOLO PERSICHETTI
In Vivo Jul 2010, 24 (4) 575-578;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Primary Amyloidosis of the Eyelid: A Case Report
ALESSIO CAGGIATI, ANTONNIO CAMPANELLA, STEFANIA TENNA, ANNALISA COGLIANDRO, CLEMENTE POTENZA, PAOLO PERSICHETTI
In Vivo Jul 2010, 24 (4) 575-578;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study
  • Pediatric Patients With Sickle Cell Disease at a Public Hospital: Nutrition, Compliance and Early Experience With L-Glutamine Therapy
  • Five-year Follow-up of Patients With Head and Neck Cancer Treated With Nivolumab and Long-term Responders for Over Two Years
Show more Clinical Studies

Similar Articles

In Vivo

© 2022 In Vivo

Powered by HighWire